Events

In this program, a panel of retina specialists share their insights into the use of newer anti-VEGF agents, which offer the opportunity for extended treatment intervals for the treatment of retinal vein occlusion (RVO), neovascular age-related macular degeneration, and diabetic...

This online activity is designed to update clinicians on data presented at the 25th EURETINA Congress that was held from September 4 to 7, 2025, in Paris, France; the 59th Annual Meeting of the Retina Society that was held on...

In the rapidly expanding oncology treatment landscape, multidisciplinary care is essential for managing any treatment-related adverse events. This program will provide eye care clinicians with the knowledge and competence to manage ocular toxicities associated with antibody-drug conjugates, monoclonal antibodies, and...

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding the management of DED and share their perspectives and best...

This online, on-demand virtual symposium brings together renowned retina specialists to discuss the treatment of macular telangiectasia (MacTel) type 2, which is a rare, progressive retinal disease. In this educational program, these experts discuss recent innovations in approved therapy for...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

This online, on-demand virtual symposium brings together renowned experts in the treatment of Demodex blepharitis. In this educational program, these experts review the diagnostic steps for Demodex blepharitis and discuss the efficacy and safety of available agents to address this...

The BURST CME™ format is an online, on-demand video program designed to deliver concise, modular education. In these modules, Uday Devgan, MD, FACS, FRCS, reviews presbyopia-correcting intraocular lenses (IOLs) and toric IOLs for patients with astigmatism. Topics discussed include the...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...